1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ricinoleic acid in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ricinoleic acid) | Trials (ricinoleic acid) | Recent Studies (post-2010) (ricinoleic acid) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 203 | 0 | 79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, A; Capasso, F; Tavares, IA | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ricinoleic acid
| Article | Year |
|---|---|
PAF formation by human gastrointestinal mucosa/submucosa in-vitro: release by ricinoleic acid, and inhibition by 5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Calcimycin; Gastric Mucosa; Humans; In Vitro Techniques; Intestinal Mucosa; Mesalamine; Platelet Activating Factor; Ricinoleic Acids | 1992 |